Venous Thromboembolism Prophylaxis
Cross-source consensus on Venous Thromboembolism Prophylaxis from 1 sources and 4 claims.
1 sources · 4 claims
How it works
Risks & contraindications
Comparisons
Highlighted claims
- VTE is a leading cause of preventable morbidity among hospitalized patients. — Physician beliefs regarding venous thromboembolism prophylaxis at a large multihospital US healthcare system: a cross-sectional survey study
- Multiple national guidelines recommend restricting thromboprophylaxis to high-risk patients only, while the National Quality Forum supports universal risk assessment rather than universal treatment. — Physician beliefs regarding venous thromboembolism prophylaxis at a large multihospital US healthcare system: a cross-sectional survey study
- The Joint Commission requires all medical inpatients to either receive prophylaxis or have a documented contraindication, but being low-risk is not formally penalized as a reason to withhold it. — Physician beliefs regarding venous thromboembolism prophylaxis at a large multihospital US healthcare system: a cross-sectional survey study
- Heparin-based prophylaxis reduces VTE incidence but carries real risks including major bleeding and heparin-induced thrombocytopenia. — Physician beliefs regarding venous thromboembolism prophylaxis at a large multihospital US healthcare system: a cross-sectional survey study